Video

CURE New Issue Alert: 2020 Hematology Special Edition-1

Here are the latest highlights from the first CURE Hematology Special Edition issue for 2020.

Hi, I’m Jessica Skarzynski for CURE Magazine®, your guide to every stage of the cancer experience.

Here’s a look at what’s inside our 2020 Winter Hematology special issue:

For decades the treatment for acute myeloid leukemia remained the same — intensive chemotherapy. But a wave of new targeted therapies in recent years have expanded options for patients while helping them live longer and better lives. We delve into how oncologists are changing up therapy by Making It Personal.

Next, Eyes are on Immunotherapy for patients with relapsed and resistant diffuse large B-cell lymphoma. Our feature story discusses new treatments beyond tried-and-true chemotherapy.

To read these stories and more, visit our publications here and click on the latest CURE cover.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit here for more information.

And, as always, thanks for reading.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Image of woman.